Where Interleukin-1 beta is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Low Back Pain | ↑ elevated | control discs | — | Kang et al. 1996 |
| Major Depressive Disorder | ↑ elevated | healthy controls | — | Lorkiewicz et al. 2021 |
Frequently asked questions
In which conditions is Interleukin-1 beta altered?
In the OSMF atlas Interleukin-1 beta is reported in Low Back Pain, Major Depressive Disorder. It is elevated in 2 across 2 entries.
Does Interleukin-1 beta point to one specific diagnosis?
No. Because Interleukin-1 beta changes in several conditions (Low Back Pain, Major Depressive Disorder), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
Is there a standard clinical test for Interleukin-1 beta?
The atlas entries for Interleukin-1 beta do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Interleukin-1 beta result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.